BioSpace Movers & Shakers, Nov. 6
The Pharma Data
NOVEMBER 5, 2020
X4 Pharmaceuticals – Art Taveras was named CSO of Cambridge, Mass.-based Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies. Prior to this, he held a position as a director of Analytical Chemistry in Drug Discovery at GlaxoSmithKline.
40 
Let's personalize your content